Can dual blockade of the renin–angiotensin system reduce progression of kidney disease beyond monotherapy?

Author： Brewster Ursula C Perazella Mark A

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.3, Iss.1, 2004-01, pp. : 9-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improving BP Control with Combined Renin-Angiotensin System Blockade and Thiazide Diuretics in Hypertensive Patients with Diabetes Mellitus or Kidney Disease

By Palmer Biff F.

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 1, 2008-01 ,pp. : 9-14

Adis International

Access to resources Recommend Favorite

The Reno-Protective Effect of the Dual Blockade of the Renin Angiotensin System (RAS)

Current Pharmaceutical Design, Vol. 11, Iss. 10, 2005-04 ,pp. : 1291-1300

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Renin-Angiotensin System in Cardiovascular Disease

By Cohn Jay

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 341-344

Springer Publishing Company

Access to resources Recommend Favorite

An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy

By García-Donaire Jose Antonio Segura Julian Ruilope Luis Miguel

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1587-1596

Informa Healthcare

Access to resources Recommend Favorite

The Therapeutic Implications of Renin-Angiotensin System Blockade in Diabetic Retinopathy

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 392-395

Bentham Science Publishers

Access to resources Recommend Favorite